1. Decreased expression of microRNAs targeting type-2 diabetes susceptibility genes in peripheral blood of patients and predisposed individuals
   Ioanna Kokkinopoulou et al, 2019, Endocrine CrossRef
2. Diabetic Cardiomyopathy
   Guanghong Jia et al, 2018, Circulation Research CrossRef
3. Isolated downregulation of HCN2 in ventricles of rats with streptozotocin-induced diabetic cardiomyopathy
   Katarina Hadova et al, 2021, BMC Cardiovascular Disorders CrossRef
4. Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes
   Madhu Khullar et al, 2017, Frontiers in Endocrinology CrossRef
5. Current advances in the study of diabetic cardiomyopathy: From clinicopathological features to molecular therapeutics (Review)
   Lin Sun et al, 2019, Molecular Medicine Reports CrossRef
6. Inhibition of miR‑186‑5p contributes to high glucose‑induced injury in AC16 cardiomyocytes
   Jiamei Jiang et al, 2017, Experimental and Therapeutic Medicine CrossRef
7. Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets
   Misganaw Asmamaw Mengstie et al, 2022, Frontiers in Endocrinology CrossRef
8. MiR-451 antagonist protects against cardiac fibrosis in streptozotocin-induced diabetic mouse heart
   Cui Liang et al, 2019, Life Sciences CrossRef
9. Inhibition of long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 attenuates high glucose-induced cardiomyocyte apoptosis via regulation of miR-181a-5p
   Yongxia Cheng et al, 2020, Experimental Animals CrossRef
10. Epigenetics of Circadian Rhythm Disruption in Cardiovascular Diseases
    Ivana Škrlec, 2021, Cardiac Diseases - Novel Aspects of Cardiac Risk, Cardiorenal Pathology and Cardiac Interventions CrossRef
11. Role of MicroRNA-34a in Anti-Apoptotic Effects of Granulocyte-Colony Stimulating Factor in Diabetic Cardiomyopathy
    In-Hwa Park et al, 2020, Diabetes & Metabolism Journal CrossRef
12. Application of Animal Models in Diabetic Cardiomyopathy
    Wang-Soo Lee et al, 2021, Diabetes & Metabolism Journal CrossRef
13. LncRNA H19 inhibits ER stress induced apoptosis and improves diabetic cardiomyopathy by regulating PI3K/AKT/mTOR axis
    Sixuan Wang et al, 2022, Aging CrossRef
14. Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP
    Ping Fang et al, 2023, Drug Design, Development and Therapy CrossRef
15. Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers
    Perry V. Halushka et al, 2019, Annual Review of Pathology: Mechanisms of Disease CrossRef
16. Right ventricular dysfunction and remodeling in diabetic cardiomyopathy
    Yin Kang et al, 2019, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
17. Epigenetic signatures in cardiac fibrosis, special emphasis on DNA methylation and histone modification
    Hui Tao et al, 2018, Heart Failure Reviews CrossRef
18. The impact of epigenetics on cardiovascular disease
    Dimple Prasher et al, 2020, Biochemistry and Cell Biology CrossRef
19. miR-410-5p promotes the development of diabetic cardiomyopathy by suppressing PIM1-induced anti-apoptosis
    Xiaofen Xia et al, 2020, Molecular and Cellular Probes CrossRef
20. Diabetic cardiomyopathy: the need for adjusting experimental models to meet clinical reality
    Frank Lezoualc’h et al, 2023, Cardiovascular Research CrossRef
21. Effect of Selenium Nanoparticles and/or Bee Venom against STZ-Induced Diabetic Cardiomyopathy and Nephropathy
    Mona M. Lotfy et al, 2023, Metabolites CrossRef